Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Article | Time | Date | Source |
|---|---|---|---|
| Vertex Signs Deal With Bristol-Myers for Hepatitis C Treatment Studies | 8:42 AM | Apr 5, 2013 | Dow Jones Global News Select |
| Vertex Enters Agreement with Bristol-Myers Squibb -2- | 7:59 AM | Apr 5, 2013 | PR |
| Vertex Enters Agreement with Bristol-Myers Squibb for Phase 2 All-Oral Studies of VX-135 in Combination with Daclatasvir for the Treatment of Hepatitis C | 7:59 AM | Apr 5, 2013 | PR |
| Vertex to Report First Quarter 2013 Financial Results on Tuesday, April 30 | 4:15 PM | Apr 1, 2013 | PR |
| Morning Research on Amgen, Affymax, Vertex Pharma, Questcor Pharma, and Repros Therapeutics | 8:01 AM | Apr 1, 2013 | PR |
| Low-Quality Stocks Have Zoomed. Time to Shift Gears? | 6:23 PM | Mar 22, 2013 | WSJ.com |
| Pushing Pipelines Forward for Long-Term Success - Research Report on Vertex, Santarus, Arena Pharmaceuticals, Seattle Genetics and Nektar Therapeutics | 8:01 AM | Mar 8, 2013 | PR |
| FDA Drug Approvals Increase | 4:54 PM | Dec 5, 2012 | WSJ.com |
